Free Access
Vet. Res.
Volume 34, Number 3, May-June 2003
Page(s) 317 - 330
How to cite this article Vet. Res. (2003) 317-330
  1. Barrett A.J., Alpha 2-macroglobulin. Methods Enzymol. 80 (1981) 737-754.
  2. Borgtröm A., Ohlsson K., Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma, Scand. J. Clin. Lab. Med. 36 (1976) 809-814.
  3. Borzotta A.P., Polk H.C., Multiple system organ failure, Surg. Clin. N. Am. 63 (1983) 315-336.
  4. Brodrick J.W., Largman C., Johnson J.H., Geokas M.C., Human cationic trypsinogen, J. Biol. Chem. 253 (1978) 2732-2736 [PubMed].
  5. Brodrick J.W., Geokas M.C., Largman C., Fassett M., Johnson J.H., Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera, Am. J. Physiol. 237 (1979) E474-E480 [PubMed].
  6. Deby-Dupont G., Haas M., Pincemail J., Braun M., Lamy M., Deby C., Franchimont P., Immunoreactive trypsin in adult respiratory distress syndrome, Intensive Care Med. 10 (1984) 7-12 [CrossRef] [PubMed].
  7. Deby-Dupont G., Grulke S., Caudron I., Mathy-Hartert M., Benbarek H., Deby C., Lamy M., Serteyn D., Equine neutrophil myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies, Vet. Immunol. Immunopathol. 66 (1998) 257-271 [PubMed].
  8. Diamond J.M., Reabsorption of digestive enzymes: playing with poison, Nature 271 (1978) 111-112 [CrossRef].
  9. Feeney R.E., Means G.E., Bigler J.C., Inhibition of human trypsin, plasmin and thrombin by naturally occurring inhibitors of proteolytic enzymes, J. Biol. Chem. 244 (1969) 1957-1960 [PubMed].
  10. Figarella C., Negri G.A., Guy O., The two human trypsinogens. Inhibition spectra of the two human trypsins derived from their purified zymogens, Eur. J. Biochem. 53 (1975) 457-463 [PubMed].
  11. Florholmen J., Jorde R., Olsen R.L., Kolmannskog S., Burhol P.G., Radioimmunoassay of cationic trypsin-like immunoreactivity in man, Scand. J. Gastroenterol. 19 (1984) 613-621 [PubMed].
  12. Florholmen J., Revhaug A., Burhol P.G., Giercksky K.E., Olsen R., Effect of intravenous and intraduodenal administration of Escherichia coli endotoxin on the porcine pancreas as evaluated by changes in the serum cationic trypsin-like immunoreactivity, Scand. J. Gastroenterol. 20 (1985) 279-284 [PubMed].
  13. Florholmen J., Revhaug A., Burhol P.G., Lundgren T.I., Giercksky K.E., Effect of hemorrhagic and nortriptyline-induced shock on the porcine pancreas as evaluated by changes in serum cationic trypsin-like immunoreactivity, Scand. J. Gastroenterol. 20 (1985) 720-726 [PubMed].
  14. Florhomen J., Riepl R., Almdahl S.M., Myklebust R., Burhol P.G., Giercksky K.E., Malm D., Impact of experimental endogenous gram-negative peritonitis on the pancreas of the rat as evaluated by cationic trypsin-like immunoreactivity in peritoneal fluid and serum and by electron microscopy of pancreatic tissue, Scand. J. Gastroenterol. 22 (1987) 313-320 [PubMed].
  15. Florholmen J., Lindal S., Rokke O., Olsen R., Burhol P.G., Revhaug A., Effects of endotoxin on the pancreatic ultrastructure, APMIS 96 (1988) 991-996 [PubMed].
  16. Geokas M.C., Largman C., Brodrick J.W., Johnson J.H., Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay, Am. J. Physiol. 236 (1979) E77-E83 [PubMed].
  17. Gmaz-Nikulin E., Nikulin A., Plamenac P., Hegewald G., Gaon D., Pancreatic lesions in shock and their significance, J. Pathol. 135 (1981) 223-236 [PubMed].
  18. Greenwood F.C., Hunter W., Glover J., The preparation of 131I-labelled human growth hormone in high specific radioactivity, Biochem. J. 89 (1963) 114-123 [PubMed].
  19. Grulke S., Gangl M., Deby-Dupont G., Caudron I., Deby C., Serteyn D., Plasma trypsin level in horses suffering from acute intestinal obstruction, Vet. J. 163 (2002) 283-291 [CrossRef] [PubMed].
  20. Hales C.N., Randle P.J., Immunoassay of insulin with insulin antibody precipitate, Biochem. J. 88 (1963) 137-146 [PubMed].
  21. Harris C.I., Hofman T., Studies on equine trypsinogen and trypsin, Biochem. J. 114 (1969) 82.
  22. Hegewald G., Nikulin A., Gmaz-Nikulin E., Plamenac P., Bärenwald G., Ultrastructural changes of the human pancreas in acute shock, Pathol. Res. Pract. 179 (1985) 610-615 [PubMed].
  23. Hiltebrand L.B., Krejci V., Banic A., Erni D., Wheatley A.M., Sigurdsson G.H., Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock, Crit. Care Med. 28 (2000) 3233-3241 [CrossRef] [PubMed].
  24. Iwaki K., Ogawa M, Kitahara T., Tanaka S., Kosaki G., Influence of inactivation of trypsin on immunoreactivity and serum immunoreactive trypsin concentration measured by radioimmunoassay, Enzyme 29 (1983) 153-159 [PubMed].
  25. Lamy M., Faymonville M.E., Deby-Dupont G., Shock pancreas: a new entity? in: Vincent J.L. (Ed.), Update in Intensive Care and Emergency Medicine, Springer, Berlin, 1987, pp. 148-154.
  26. Liebow C., Rothman S.S., Enteropancreatic circulation of digestive enzymes, Science 189 (1975) 472-474 [CrossRef].
  27. Lottenberg R., Hall J.A., Blinder M., Binder E.P., Jackson C.M., The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions, Biochim. Biophys. Acta 742 (1983) 539-557 [PubMed].
  28. Lucas C.E., Ledgerwood A.M., The fluid problem in the critically ill, Surg. Clin. North Am. 63 (1983) 439-454 [PubMed].
  29. Mallory P.A., Travis J., Human pancreatic enzymes. Characterization of anionic human trypsin, Biochemistry 12 (1973) 2847-2851 [CrossRef] [PubMed].
  30. Malvano R., Marchisio M., Massaglia A., Giacosa P.A., Zannino M., Andriulli A., Burlina A., Radioimmunoassay of trypsin-like substance in human serum, Scand. J. Gastroenterol. 15 Suppl. 62 (1980) 2-10.
  31. Meyer W.J., Ducker T.B., Central nervous system function in critical care, Surg. Clin. North Am. 63 (1983) 401-416 [PubMed].
  32. Mitsuoka H., Kistler E.B., Schmid-Schonbein G.W., Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes, Proc. Natl. Acad. Sci. USA 97 (2000) 1772-1777 [CrossRef] [PubMed].
  33. Moore J.N., White N.A., Berg J.N., Trim C.M., Garner H.E., Endotoxemia following experimental intestinal strangulation obstruction in ponies, Can. J. Comp. Med. 45 (1981) 330-332 [PubMed].
  34. Morris D.D., Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis, J. Vet. Int. Med. 5 (1991) 167-181.
  35. Nicod L., Leuenberger C., Seydoux C., Rey F., Van Melle G., Perret C.L., Evidence for pancreatic injury in adult respiratory distress syndrome, Am. Rev. Respir. Dis. 131 (1985) 696-699 [PubMed].
  36. Ohlsson K., Skude G., Demonstration and semiquantitative determination of complexes between various proteases and human $\alpha_2$-macroglobulin, Clin. Chem. Acta 66 (1976) 1-7 [CrossRef].
  37. Rinderknecht H., Pancreatic secretory enzymes, in: Vay Liang W. Go, Dimagno E.P., Gardner J.D., Lebenthal E., Reber H.A., Scheele G.A. (Eds.), The Pancreas Biology, Pathobiology and Disease, Raven Press, Ltd., New York, 1993, pp. 219-251.
  38. Rinderknecht H., Fleming R.M., Geokas M.C., Effect of $\alpha_2$-macroglobulin on some kinetic parameters of trypsin, Biochim. Biophys. Acta 377 (1975) 158-165 [PubMed].
  39. Siegel J.H., Cardiorespiratory manifestations of metabolic failure in sepsis and the multiple organ failure syndrome, Surg. Clin. North Am. 63 (1983) 379-399 [PubMed].
  40. Shapiro A.L., Vinuela E., Maizel J.V. Jr., Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels, Biochem. Biophys. Res. Commun. 28 (1967) 815-820 [CrossRef] [PubMed].
  41. Snyder J.R., The pathophysiology of intestinal damage: effects of luminal distention and ischemia, Vet. Clin. North Am. Equine Pract. 5 (1989) 247-270.
  42. Starkey P.M., Barrett A.J., Evolution of alpha 2-macroglobulin. The demonstration in a variety of vertebrate species of a protein resembling human alpha 2-macroglobulin, Biochem. J. 205 (1982) 91-95 [PubMed].
  43. Steiner J.M., Medinger T.L., Williams D.A., Development and validation of a radioimmunoassay for feline trypsin-like immunoreactivity, Am. J. Vet. Res. 57 (1996) 1417-1420 [PubMed].
  44. Svendsen L., Blomback B., Blomback M., Olsson P.I., Substrates for determination of trypsin, thrombin and thrombin-like enzymes, Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 98 (1972) 446-454 [PubMed].
  45. Temler R.S., Felber J.P., Radioimmunoassay of human plasma trypsin, Biochim. Biophys. Acta 445 (1976) 720-728 [PubMed].
  46. Travis J., Roberts R.C., Human trypsin. Isolation and physical-chemical characterization, Biochemistry 8 (1969) 2884-2889 [CrossRef] [PubMed].
  47. Tribl B., Madl C., Mazal P.R., Schneider B., Spitzauer S., Vogelsang H., Gangl A., Exocrine pancreatic function in critically ill patients, Crit. Care Med. 28 (2000) 1393-1398 [CrossRef] [PubMed].
  48. Vaitukaitis J., Robbin J.B., Nieschlag E., Ross G.T., A method for producing specific antisera with small doses of immunogen, J. Clin. Endocrinol. Metab. 33 (1971) 988-991 [PubMed].
  49. Walsh K.A., Trypsinogens and trypsins of various origins, Methods Enzymol. 19 (1970) 41-63.
  50. Warshaw A.L., O'Hara P.J., Susceptibility of the pancreas to ischemic injury in shock, Ann. Surg. 188 (1978) 197-201 [PubMed].
  51. Westermeier R., Postel W., Görg A., Horizontal SDS electrophoresis in buffer-equilibrated pore-gradient polyacrylamide gels, Science Tools 32 (1985) 32-33.
  52. Williams D.A., Batt R.M., Sensitivity and specficity of radioimmunossay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency, J. Am. Vet. Med. Assoc. 192 (1988) 195-201 [PubMed].